{"id":"W2621872277","doi":"10.1016/j.ejca.2017.05.003","title":"Corrigendum to ‘Phase Ib dose-finding study of abiraterone acetate plus buparlisib (BKM120) or dactolisib (BEZ235) in patients with castration-resistant prostate cancer’ [European Journal of Cancer 76 (2017) 36–44]","year":2017,"lang":"en","type":"erratum","venue":"European Journal of Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Abiraterone acetate; Prostate cancer; Medicine; PI3K/AKT/mTOR pathway; PTEN; Internal medicine; Androgen receptor; Cancer research; Oncology; Cancer; Chemistry; Androgen deprivation therapy; Apoptosis; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005447017,0.001958691,0.003237631,0.002764644,0.001849175,0.002986882,0.003920011,0.009933815,0.04784346],"category_scores_gemma":[0.04224158,0.001405315,0.00358693,0.001686189,0.001536894,0.00164437,0.001826239,0.009978415,0.0267857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004646082,"about_ca_system_score_gemma":0.005480015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02709087,"about_ca_topic_score_gemma":0.05246857,"domain_scores_codex":[0.9952118,0.0007953948,0.0009839187,0.0006362515,0.001883738,0.0004890155],"domain_scores_gemma":[0.981482,0.0053195,0.00154248,0.0008859486,0.009506265,0.001263806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004229132,0.000008698906,0.00004411476,0.00006744516,0.00001467009,0.0001353106,0.000005222707,0.00002533582,0.00002918679,0.00008944761,0.9964396,0.003098696],"study_design_scores_gemma":[0.0001544884,0.00006873307,0.001326883,0.0002478078,0.00008244037,0.0004046926,0.00001979722,0.0002039625,0.0001891205,0.0005157746,0.996748,0.00003822654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.00007421357,0.003126766,0.0002881466,0.08785434,0.905662,0.00003970692,0.0007557694,0.0001789056,0.002020115],"genre_scores_gemma":[0.003221139,0.008607035,0.00189421,0.3334832,0.5336456,0.0001520573,0.002479462,0.0004730933,0.1160443],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.04784346,"threshold_uncertainty_score":0.1600523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08206746764147864,"score_gpt":0.3813537497478732,"score_spread":0.2992862821063945,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}